drug · small molecule
psilocybin
Phase 3updated 5mo agoby $CMPS COMPASS Pathways plc🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 7- drugOral Psilocybin6 co-mentions · 6 sources
- drug(aeruginascin + baeocystin + psilocybin)6 co-mentions · 6 sources
- drugMYCO-0036 co-mentions · 6 sources
- drugPsilocybin (Microneedle Patch)6 co-mentions · 6 sources
- companyNew York University1 co-mentions · 1 sources
- tagPsychiatry & CNS1 co-mentions · 1 sources
- tagPain1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 35 investigational indications.
indications
indications
Major DepressionObesity
targets
5-hydroxytryptamine receptor 2A
all catalysts(0)
nothing on the calendar yet
Trials studying psilocybin
- phase1ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
- phase1MLS101 Study in PMDD
- phase3The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
- phase2A Study of Psilocybin for Major Depressive Disorder (MDD)
- EP1Exploratory Study of Low Dose Psilocybin
- phase2Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- phase1A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers
- phase3Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
News(10)
- How J&J paved the way for Compass’ coming psychedelic drug launchIn an interview with BioPharma Dive, Compass executives said that, should the FDA approve their treatment, they hope to capitalize on a strategy pioneered by J&J in selling the ketamine spray Sprav…biopharma_dive · 13d ago
- Deep dive: Psychedelics back on FDA’s doorstepBioSpace takes stock of the psychedelic therapeutics space, which is once again on the cusp of its first FDA approval.biospace · 18d ago
- Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near marketSafety and access were top of mind at Monday’s public hearing exploring the regulation of psychedelic therapies. "The medicine opens the door,” NeuroAlchemy co-founder Michaela Vogt said during the…biospace · 19d ago
- As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safetyAs the FDA marches toward the likely first approval of a psychedelic medicine, the agency today convened a hearing seeking public input on how these drugs should be used, monitored and continuously…fiercebiotech · 20d ago
- Psychedelic therapies ride wave of public favor into FDA hearingHeading into an FDA hearing on Monday regarding the future of psychedelic treatments, public comments show wide support for further exploring the therapeutic potential of these compounds—to match r…biospace · 21d ago
- Compass posts positive psilocybin data; Solstice makes $225M debutPlus news about Luma, Inno Medicine, Schrödinger, Assembly Biosciences, Gilead, Leyden Labs, Navion, Ridge Bio, and Opus Genetics. 📊 Compass Pathways touts one-year data for psilocybin drug: The b…endpoints · 25d ago
- Psilocybin proves promising in neuropathic pain mouse studyAmid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.fiercebiotech · 1mo ago
- STAT+: How a Trump loyalist got the FDA nominationWhat you need to know about Heidi Overton, and Erica Schwartz's first speech to CDC staff.stat · 1mo ago
- Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy.stat · 1mo ago
- Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: AnalystsIf confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics a…biospace · 1mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that